Emerald is a London-based preventive healthcare platform founded in 2024 that combines in-clinic laboratory blood screening with a digital platform unifying test results, wearable data and health history. Each member is paired with a GP who can diagnose, prescribe and make referrals into private or NHS care, and the service is distributed through employee-benefits partnerships including Pluxee, Epassi and Yonder. The company is clinician-founded, Care Quality Commission registered, and its platform is authorised as a UKCA Class I medical device.
1
Round
1
Industry
5
Tags
Oct 20, 2026
Latest raise
Funding activity · 1 round
Oct 20, 2026
GBP 700,000
Seed
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
